TSH modulation in advanced differentiated thyroid cancer: a continuous walk on the tightrope between prognostic stratification, adverse events, and levothyroxine bioavailability.
Minerva Endocrinol (Torino)
; 47(1): 99-102, 2022 03.
Article
in En
| MEDLINE
| ID: mdl-33213117
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Thyroid Neoplasms
/
Adenocarcinoma
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Minerva Endocrinol (Torino)
Year:
2022
Document type:
Article
Country of publication:
Italy